Additional file 1 of Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions
Additional file 1: Figure S1. Analyses for which the mean annual volumes were not modified by the feasibility study results. Comparison of the volumes of tests reported by the Belgian laboratories of clinical pathology for 6 different years: group A (light grey bars, period before the presentation of the results of the feasibility study [data collected for 2014 and 2015]) versus group B (dark grey bars, period after the presentation of the results of the feasibility study [data collected for 2016 and 2017]) versus group C (black bars, period from RLs’ recognition [data collected for 2019 and 2... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Image |
Erscheinungsdatum: | 2021 |
Schlagwörter: | Medicine / Sociology / Science Policy / Biological Sciences not elsewhere classified / Rare diseases / Clinical pathology / Financing / Reference laboratories / Reimbursement codes / Expertise |
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-28874969 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.6084/m9.figshare.14053554.v1 |